Answers are grounded in this paper and cite their sources.
Findings highlight potential benefits of stiripentol in Lennox-Gastaut syndrome, suggesting further evaluation is needed.
Although this study was conducted before standardized clinical trial designs for LGS were established, a more comprehensive evaluation of stiripentol could have provided further insight into its potential benefits in this severe developmental and epileptic encephalopathy.
No takes yet. Share an insight, caveat, or question.
Auvin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: